This compound is intended for research use only, and its applications outside of laboratory settings have not been established
TRIUMPH-CVOT: cardiovascular outcomes trial, approximately 10,000 participants with established CVD, primary endpoint major adverse cardiovascular events (MACE), timeline 3 to 4 years
Teixeira CFP, Landucci ECT, Antunes E, Chacur M, Cury Y (2003) Inflammatory effects of snake venom myotoxic phospholipases A2
Its used to treat several skin diseases that are connected to inflammation including atopic dermatitis, rosacea or eczema
These interactions are further complicated by metabolic conditions such as obesity and diabetes, where hormonal resistance (e.g., leptin, insulin) and neurotransmitter dysregulation contribute to altered taste preferences and compulsive eating behaviors